Hidetoshi Shimizu
Overview
Explore the profile of Hidetoshi Shimizu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
84
Citations
248
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Koide Y, Aoyama T, Noguchi M, Shindo Y, Kitagawa T, Shimizu H, et al.
J Radiat Res
. 2025 Jan;
66(1):89-96.
PMID: 39812364
This study aimed to evaluate the recent trends in single-fraction conventional radiotherapy (CRT) as palliative treatment in Japan, using data from the National Database published by the Ministry of Health,...
2.
Koide Y, Shindo Y, Noguchi M, Kitagawa T, Aoyama T, Shimizu H, et al.
Int J Radiat Oncol Biol Phys
. 2024 Dec;
121(5):1125-1133.
PMID: 39672517
Purpose: A novel classification system has been proposed to stratify patients undergoing palliative radiation therapy based on their pain response and time to progression. This study used prospective observational data...
3.
Watanabe Y, Koide Y, Shimizu H, Aoyama T, Shindo Y, Hashimoto S, et al.
Cancers (Basel)
. 2024 Oct;
16(19).
PMID: 39409877
Despite advancements in treatment for patients with unresectable locally advanced non-small cell lung cancer (LA-NSCLC), overall survival (OS) remains poor. The specific effects of varying heart and lung doses on...
4.
Ogasawara A, Kojima K, Murata Y, Shimizu H
Br J Clin Pharmacol
. 2024 Oct;
91(2):451-463.
PMID: 39367654
Aims: Dersimelagon is a novel, investigational, orally administered, selective agonist of the melanocortin-1 receptor that has demonstrated efficacy at increasing symptom-free light exposure and an acceptable safety profile in patients...
5.
Shimizu H, Nakamura O, Sasaki K, Aoyama T, Kitagawa T, Kodaira T
J Appl Clin Med Phys
. 2024 Sep;
25(11):e14497.
PMID: 39264235
Purpose: Total body irradiation before bone marrow transplantation for hematological malignancies using Radixact, a high-precision radiotherapy machine, can potentially reduce side effects and the risk of secondary malignancies. However, stable...
6.
Aoyama T, Koide Y, Shimizu H, Urikura A, Kitagawa T, Hashimoto S, et al.
Jpn J Radiol
. 2024 Sep;
43(1):109-116.
PMID: 39240460
Purpose: This study aimed to analyze the domestic and international landscape of imaging diagnostics and treatments, focusing on Japan, to provide current insights for policymaking, clinical practice enhancement, and international...
7.
Shimizu H
Nihon Hoshasen Gijutsu Gakkai Zasshi
. 2024 Aug;
80(8):868-874.
PMID: 39168597
No abstract available.
8.
Shimizu H, Tortorici M, Ohta Y, Ogawa K, Rahman S, Fujii A, et al.
Clin Transl Sci
. 2024 Aug;
17(8):e70000.
PMID: 39152532
Dysregulation of the mineralocorticoid hormone aldosterone is an increasingly prevalent cause of hypertension. Aldosterone synthase (CYP11B2) shares 93% homology to 11β-hydroxylase (CYP11B1), which produces cortisol. Lorundrostat, a highly selective inhibitor...
9.
Shimizu H, Kodaira T, Kiyota N, Hayashi R, Nishino H, Asada Y, et al.
Oral Oncol
. 2024 Aug;
157():106976.
PMID: 39111143
Background And Purpose: Hypothyroidism is a recognized late adverse event following radiotherapy for head and neck cancer (HNC). In the JCOG1008 trial, we treated patients with high-risk HNC with postoperative...
10.
Shimizu H, Koide Y, Haimoto S, Aoyama T, Tachibana H, Hashimoto S, et al.
J Neurooncol
. 2024 Jul;
169(3):563-570.
PMID: 39046598
Purpose: This study aimed to identify factors associated with local recurrence after spinal stereotactic body radiation therapy (SBRT), focusing on patient movement during treatment and tumor characteristics. Methods: A total...